Skip to main content
Clinical Trials/NCT02381054
NCT02381054
Completed
N/A

Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients

Italian PRO-CTCAE Study Group16 sites in 1 country233 target enrollmentMay 2015
ConditionsCancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
Italian PRO-CTCAE Study Group
Enrollment
233
Locations
16
Primary Endpoint
cultural and linguistic validity of Italian language version of the PRO-CTCAE
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to see if the Italian language version of a questionnaire about symptoms that patients may have during cancer treatment is understandable to Italian speaking patients. The questionnaire is called the PRO-CTCAE, and was originally developed at the U.S. National Cancer Institute to help get information about patients' symptoms directly from the patients themselves. The Italian version of the questionnaire will be used in future studies to gain a better understanding of patient symptoms.

Detailed Description

This study will be conducted in two steps. The first is the Italian translation and cross cultural adaptation of the original US NCI's version of the PRO-CTCAE questionnaire. The questionnaire will be translated and administered to a sample of 96 Italian patients. After protocol amendment in November 2016, the second step was modified and consists of test-retest reliability assessment of the Italian language version of the PRO-CTCAE questionnaire that was developed in the first step, with a minimum of 59 Italian speaking patients to be enrolled. A validation study is planned and will be the subject of a separate protocol.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
June 22, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Italian PRO-CTCAE Study Group
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥18 years of age.
  • Patient is able to complete PRO-CTCAE on two consecutive days.
  • Patient is actively receivingmedical treatment for cancer or has completed treatment not more than 4 weeks before Visit 1
  • Any type of cancer
  • Able to complete questionnaire by themselves or with assistance.
  • Providing informed written consent.
  • Able to speak and understand Italian

Exclusion Criteria

  • Clinically significant cognitive or memory impairment in the opinion of clinical or research staff.
  • Other important acute medical conditions that, in the opinion of the Investigator, may prevent compliance..

Outcomes

Primary Outcomes

cultural and linguistic validity of Italian language version of the PRO-CTCAE

Time Frame: 2 years

Study Sites (16)

Loading locations...

Similar Trials